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ABSTRACT 27 
Cerebrospinal fluid (CSF) provides vital support for the brain. Abnormal CSF 28 
accumulation is deleterious for perinatal neurodevelopment, but how CSF leaves the brain during 29 
this critical period is unknown. We found in mice a postnatal neurodevelopmental transition 30 
phase featuring precipitous CSF K+ clearance, accompanied by water, through the choroid plexus 31 
(ChP). The period corresponds to a human fetal stage when canonical CSF clearance pathways 32 
have yet to form and congenital hydrocephalus begins to manifest. Unbiased ChP metabolic and 33 
ribosomal profiling highlighted this transition phase with increased ATP yield and activated 34 
energy-dependent K+ transporters, in particular the Na+-K+-Cl- and water cotransporter NKCC1. 35 
ChP-targeted NKCC1 overexpression enhanced K+-driven CSF clearance and enabled more 36 
permissive cerebral hydrodynamics. Moreover, ventriculomegaly in an obstructive 37 
hydrocephalus model was improved by ChP-targeted NKCC1 overexpression. Collectively, we 38 
identified K+-driven CSF clearance through ChP during a transient but critical 39 
neurodevelopmental phase, with translational value for pathologic conditions. 40 
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INTRODUCTION 45 
A balance between cerebrospinal fluid (CSF) production and clearance (influx/efflux) is 46 
essential for normal brain function and development (Fame and Lehtinen, 2020). Disrupted CSF 47 
volume homeostasis with excessive CSF accumulation is implicated in many pediatric brain 48 
disorders, in particular congenital hydrocephalus (Kahle et al., 2016), where patients suffer from 49 
a potentially life-threatening accumulation of CSF and frequently develop neurological deficits 50 
that last through childhood and into adult life (Vinchon et al., 2012). Schizophrenia patients can 51 
have enlarged lateral ventricles by their first episode of psychosis (Steen et al., 2006), and in 52 
some cases as early as infancy (Gilmore et al., 2010), suggesting a role for CSF clearance 53 
abnormalities in this and possibly other neurodevelopmental disorders. As another example, 54 
autism spectrum disorders are associated with altered CSF distribution patterns and enlarged 55 
CSF space surrounding the brain (Shen et al., 2017). A better understanding of developing CSF 56 
dynamics may help explain why early phases of brain development (e.g. from third trimester to 6 57 
months after birth in human) represent a period of high vulnerability to certain congenial 58 
disorders (Volpe, 2008, Gilmore et al., 2010, Shen et al., 2017).  59 
Critically, how CSF is cleared during this perinatal period remains a mystery. Progress in 60 
CSF dynamics research has identified several CSF clearance routes including arachnoid 61 
granulations, perineural and paravascular pathways, and meningeal lymphatics (Antila et al., 62 
2017, Munk et al., 2019, Fame and Lehtinen, 2020). However, these systems only fully appear at 63 
later stages of life (up to 2 years in human and several weeks postnatal in mice) (Antila et al., 64 
2017, Munk et al., 2019), and therefore are not available to contribute to CSF dynamics during 65 
these critical early phases. Identifying and manipulating the early endogenous CSF clearance 66 
mechanisms could provide one powerful approach for tackling neurodevelopmental disorders 67 
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involving CSF dysregulation, and may also be applied to fluid disorders affecting adults. 68 
To identify how early CSF is cleared, we investigated tissues with the ability to modulate 69 
CSF at this stage. The choroid plexus (ChP) is an intraventricular epithelial structure that forms 70 
the majority of the blood-CSF barrier and develops prenatally. It contains diverse ion and fluid 71 
transporters along its vast surface area capable of bidirectional transport (Damkier et al., 2013). 72 
Although the prevailing model posits that the ChP provides net unidirectional, luminal secretion 73 
of ions and water to form CSF, insufficient corroborating data have been collected under 74 
physiological experimental conditions. Furthermore, historical clinical observations suggest 75 
some absorptive functions of the ChP (Milhorat et al., 1970) which is supported by animal 76 
studies (Oreskovic et al., 2017). Finally, broad transcriptional changes of the machinery 77 
regulating fluid/ion transport support the concept of temporally dynamic and possibly context-78 
dependent ChP functions in determining net directionality of CSF transport (Liddelow et al., 79 
2013, Delpire and Gagnon, 2019).  80 
To further explore potentially absorptive properties of the ChP, we studied the expression 81 
of transporters, the energetic systems and ionic gradients that govern their activity, and their 82 
physiological effects across the timespan of early postnatal development in mice. Taken together 83 
our data support a novel role and mechanism for CSF clearance by the Na+-K+-Cl- and water co–84 
transporter, NKCC1, in the apical membrane of the ChP during a specific developmental period. 85 
These results have implications for the pathophysiology of congenital disorders accompanied by 86 
dysregulated CSF and could inform strategies for treatment of neonatal hydrocephalus and 87 
perhaps other disorders.  88 
 89 
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RESULTS 90 
CSF K+ declines precipitously during a specific perinatal period 91 
We discovered a unique and transient phase of neurodevelopment when CSF [K+] 92 
decreased rapidly. We used inductively coupled plasma optical emission spectrometry (ICP-OES) 93 
and ion chromatography (IC) to measure levels of key ions likely to govern CSF flux including 94 
Na+, K+, and Cl- at several developmental timepoints. CSF [K+] was remarkably high at birth 95 
(9.6 ± 3.5 mM), decreased rapidly to 4.4 ± 0.9 mM by P7 (Fig. 1A), and later achieved adult 96 
levels of 3.1 ± 0.6 mM (Fig. 1A) while [Na+] and [Cl-] were minimally changed (Fig. 1B). The 97 
reduction in CSF K+ was consistent with previous reports in other species (Saunders et al., 2018) 98 
and correlated with parallel changes in serum [K+] such that the ratio between blood and CSF 99 
[K+] remained stable (Fig. 1C).  100 
Notably, K+ transport has been associated with water co-transport by several K+ 101 
transporters in various tissues and cell types (Zeuthen, 1994, Hamann et al., 2010, Zeuthen and 102 
Macaulay, 2012), suggesting that CSF [K+] changes could drive water movement in the brain as 103 
well. Therefore, we sought to identify mechanisms underlying this fast clearance of CSF K+, 104 
which may shed light on CSF outflow during this time.  105 
 106 
ChP metabolism increases during the early postnatal transition phase 107 
We found that the transitional period of rapid CSF K+ clearance coincided with high ChP 108 
metabolism. We reasoned that K+ clearance during this period could be ChP-mediated because 109 
the ChP expresses high levels of K+ co-transporters on its large CSF-contacting surface area 110 
(Keep and Jones, 1990, Damkier et al., 2013). Similar to water and ion transport by other 111 
epithelial structures such as kidney proximal and distal tubes (Bhargava and Schnellmann, 2017), 112 
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K+ clearance from CSF by the ChP would be energy-dependent and therefore be accompanied by 113 
upregulation of ATP production and mitochondrial activity. Therefore, we evaluated the 114 
metabolic status and ATP production capacity of the ChP epithelium before, during, and after the 115 
time period of CSF [K+] reduction. We found that both mitochondria number and size increased 116 
from E16.5 to 2mo (Fig. 1D-G), while cellular glycogen load gradually decreased 117 
(Supplementary Fig. 1). Both observations are consistent with reports from ChP in other 118 
mammalian species (Netsky and Shuangshoti, 1975, Keep and Jones, 1990) and suggest 119 
functional changes in ChP oxidative metabolism. To assess this we monitored oxygen 120 
consumption to calculate basal metabolism and ATP production at embryonic day 16.5 (E16.5), 121 
postnatal day 0 (P0), P7, and adult (2 months old (2mo)) ChP explants using Agilent Seahorse 122 
XFe technology (Fig. 1H, Supplementary Fig. 2). We found that E16.5 ChP had the lowest 123 
basal respiration of all tested ages (Fig. 1I, Supplementary Fig. 2). Adult had a higher capacity 124 
for overall ATP production than E16.5 ChP, but surprisingly, P0-P7 ChP were the most 125 
metabolically active as per ATP production (Fig. 1I, J). In addition, mitochondrial subcellular 126 
distribution in ChP epithelium was biased toward the apical surface as postnatal development 127 
proceeded, with E16.5 mitochondria heavily distributed along the basal side of epithelial cells, 128 
P0 mitochondria intermediately localized, and P7 and 2mo mitochondria having more apical 129 
distribution (Fig. 1K-M, Supplementary Fig. 3). Mitochondrial subcellular localization 130 
responds to regional energy demand in other cellular processes such as migration of mouse 131 
embryonic fibroblasts and during axonal outgrowth (Schuler et al., 2017, Smith and Gallo, 2018). 132 
Together with the increase in ATP production postnatally, the shift in ChP epithelial 133 
mitochondria distribution over postnatal development suggests increasing ATP supply to meet 134 
high demand at the apical ChP surface during the early postnatal phase, concurrent with the rapid 135 
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clearance of CSF K+. This concurrence prompted us to investigate energy-dependent 136 
mechanisms whereby ChP epithelial cells might contribute to K+ clearance.  137 
The ChP increases production of CSF-facing ion and water transporters postnatally 138 
Consistent with rapid CSF K+ clearance and high ChP metabolism, we found that 139 
expression of the energy-dependent cation transport pathway components were upregulated in 140 
ChP postnatally. To unbiasedly identify candidates controlling postnatal CSF clearance through 141 
the ChP, we conducted ribosomal profiling to investigate transcripts that are prioritized for 142 
translation in embryonic (E16.5) and adult (2 mo) ChP, using Translating Ribosomal Affinity 143 
Purification (TRAP; Heiman et al., 2008). ChP epithelial cells were targeted by crossing 144 
FoxJ1:cre mice (Zhang et al., 2007) with TRAP (EGFP:L10a) mice (Heiman et al., 2008) (Fig. 145 
2A, Supplementary Fig. 4A, B), and mRNA associated with the L10a ribosomal subunit were 146 
purified for sequencing.  147 
TRAP analyses revealed 1967 differentially translated transcripts (adjusted p < 0.05) 148 
between E16.5 and 2mo adult ChP: 1119 enriched at E16.5 and 847 enriched at 2mo (Fig. 2B). 149 
Gene set and pathway analyses revealed developmentally regulated ChP programs. Adult (2mo) 150 
ChP had enriched functional gene sets associated with active transmembrane membrane 151 
transport and mitochondria, which is consistent with our abovementioned findings on 152 
metabolism changes (Fig. 2C). Specifically, cation transport was enriched, supporting the 153 
hypothesis of ChP mediating CSF K+ transport postnatally (Fig. 2C, D). Enriched pathways in 154 
the 2mo adult included secretion associated pathways named for other, better studied secretory 155 
processes, including salivary and pancreatic secretion, all of which have a special emphasis on 156 
water and ion transmembrane transport (Supplementary Fig. 4C (red), D). Consistent with a 157 
rise in fluid and ion modulating machinery, there was a striking enrichment of more 158 
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transmembrane and signal peptide-containing transcripts in adult ChP (Supplementary Fig. 4E, 159 
F). These results indicate that the ChP specifically gained fluid and ion modulatory functions 160 
postnatally.  161 
 162 
NKCC1 is poised to mediate perinatal ChP CSF K+ and water clearance  163 
 Among all fluid and ion modulating candidates with increasing postnatal expression 164 
(Supplementary Fig. 4G, H), we identified NKCC1 (Slc12a2) as the candidate most likely to 165 
mediate CSF clearance. NKCC1 is functionally related to Na+/K+-ATPase (Atp1a1 and Atp1b1), 166 
as the latter actively maintains the Na+/K+ gradient that powers NKCC1. Both Na+/K+-ATPase 167 
and NKCC1 are capable of CSF K+ clearance, but NKCC1 was of particular interest because (1) 168 
it is a co-transporter of K+ and water (Zeuthen and Macaulay, 2012, Steffensen et al., 2018); and 169 
(2) the activity of NKCC1 can be further modified by phosphorylation (Darman and Forbush, 170 
2002), lending additional control to its fluid/ion modulatory capacity. In addition, NKCC1 is 171 
particularly enriched in the ChP and does not impact broad functionality like the Na+/K+-ATPase 172 
does, both of which are ideal features for a functional therapeutic intervention target. We refined 173 
our temporal expression analyses of NKCC1, ATP1a1, ATP1b1, and Klotho (Kl), which 174 
contributes to the membrane localization of the Na+/K+-ATPase (Razzaque, 2008, Sopjani et al., 175 
2011) (Fig. 2E), by sampling weekly from P0 to P28 and then at 2mo and confirmed increased 176 
expression of transcript and protein for each component across developmental time (Fig. 2F, G, 177 
Supplementary Fig. 5). The observed changes in NKCC1 total protein were corroborated by an 178 
independent approach where the rate of ChP epithelial cell swelling under high [K+] challenge 179 
(Steffensen et al., 2018) reflected the abundance of NKCC1 protein (Fig. 2H-J, Supplementary 180 
Fig. 6).  181 
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In addition, we found particularly high levels of phosphorylated, therefore activated 182 
(Darman and Forbush, 2002), NKCC1 (pNKCC1) in the ChP of P0-P7 pups, with P7 having 183 
peak pNKCC1 levels among all postnatal ages, indicative of increased NKCC1 activity during 184 
the first postnatal week (Fig. 2G). Similar to the timeline of ChP ATP production (Fig. 1J), the 185 
timeframe of high ChP pNKCC1 was concurrent with the fast CSF [K+] decrease during the first 186 
postnatal week (Fig. 1A), suggesting a functional correlation and further confirming the 187 
significance of the early postnatal transitional period. Taken together, we identified ChP NKCC1 188 
as the top candidate for mediating postnatal CSF K+ and water clearance. 189 
 190 
NKCC1 temporal regulation requires epigenetic control that is implicated in congenital 191 
hydrocephalus 192 
We found that the temporal profile of NKCC1 expression was tightly regulated at the 193 
epigenetic level by modulators implicated in some forms of congenital hydrocephalus. The 194 
NuRD complex governs differentiation and maturation of diverse cells and tissues (Goodman 195 
and Bonni, 2019). Our previously published RNA sequencing studies (Lun et al., 2015) 196 
identified NuRD components, including the ATPase CHD family members (Chd4 being the most 197 
highly expressed), the histone deacetylases HDAC1/2, and methyl CpG-binding domain protein 198 
MBD3 in the ChP (Fig. 3A). De novo loss-of-function CHD4 mutations are implicated in some 199 
groups of children with congenital hydrocephalus and ventriculomegaly (Weiss et al., 2020). We 200 
found that CHD4 localized to nuclei in mouse ChP epithelial cells beginning at P0 (Fig. 3B). 201 
Immunoprecipitation of CHD4 identified HDAC1, HDAC2, and MBD3 by immunoblotting in 202 
mouse ChP (Fig. 3C, technical control for Co-IP protocol is shown in Supplementary Fig. 7), 203 
confirming the existence of the CHD4/NuRD complex in developing ChP. We then disrupted the 204 
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complex by generating ChP-Chd4 deficient mice. Cre was expressed in Chd4 floxed mice (Chd4 205 
fl/fl) (Williams et al., 2004) using an adeno-associated viral vector (AAV) with tropism for the 206 
ChP (AAV2/5) (Haddad et al., 2013), delivered by in utero intracerebroventricular (ICV) 207 
injection at E14.5. Chd4 transcript levels dropped to <50% by P7 (Fig. 3D). While CHD4 208 
protein levels only substantially decreased by P14 (Fig. 3E, G), we found that the developmental 209 
increase of ChP NKCC1 expression was disrupted as soon as the CHD4 protein decreased and 210 
lasted at least until P28 (Fig. 3F, G). Similar results were also observed in 4VChP (Fig. 3H, I). 211 
The expression of other developmentally regulated, functionally relevant candidates (atp1a1, 212 
atp1b1, and klotho) was not affected (data not shown). These data confirm that the NuRD/ChD4 213 
complex is one of the required components tightly regulating ChP NKCC1 developmental 214 
expression. 215 
 216 
ChP NKCC1 actively mediates CSF clearance during the early postnatal transition phase 217 
To test whether NKCC1 is indeed capable of transporting from CSF into the ChP during 218 
the period of rapid CSF [K+] decline, we induced NKCC1 overexpression (OE) in developing 219 
ChP epithelial cells using AAV2/5. NKCC1 transport directionality follows combined Na+, K+, 220 
Cl- gradients, which are close to being neutral in adult brains and likely to bias towards the CSF-221 
to-ChP direction during the early postnatal phase. NKCC1 protein level would be rate-limiting 222 
during the early postnatal time when it is already highly phosphorylated, unlike in older mice 223 
where pNKCC1 only represented a small portion of total NKCC1. The goal of this OE approach 224 
was to accelerate endogenous ChP NKCC1 transport, thereby revealing its directionality based 225 
on whether CSF [K+] clearance was enhanced or delayed.  AAV2/5-NKCC1, which expresses 226 
NKCC1 fused to an HA tag (Somasekharan et al., 2013), or control GFP virus was delivered by 227 
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in utero ICV at E14.5. Successful NKCC1 OE and increased pNKCC1 was confirmed in ChP at 228 
P0 (Fig. 4A-D). Appropriate localization to apical membranes of epithelial cells, transduction 229 
efficiency, and tissue specificity were also validated (Fig. 4E-I, Supplementary Fig. 8 A, B). 230 
Transcript levels of other K+ transporters or channels did not change following AAV2/5-NKCC1 231 
transduction (Supplementary Fig. 8C). Because CSF [K+] sharply decreased from P0 to P7 (Fig. 232 
1A), we sampled CSF from ChP NKCC1 OE and control mice at P1. We found that ChP 233 
NKCC1 OE reduced CSF [K+] more than controls, with their P1 CSF [K+] values closely 234 
approximating those normally observed at P7 (Fig. 4J), indicating accelerated K+ clearance from 235 
CSF after enhanced ChP NKCC1 activity. CSF total protein levels were not affected (AAV2/5-236 
GFP = 2.50 ± 0.20 mg/ml vs. AAV2/5-NKCC1 = 2.71 ± 0.46 mg/ml; N = 6 from two litters each; 237 
p = 0.34, unpaired t-test). Overall, these findings support a model in which, under physiological 238 
conditions with high early postnatal CSF [K+], ChP NKCC1 transports K+ out of CSF. 239 
Next, we found that the circulating CSF volume in ChP NKCC1 OE mice was reduced, 240 
as reflected by smaller lateral ventricles. To avoid any tissue processing artifacts, we conducted 241 
live T2-weighted magnetic resonance imaging (MRI) (Fig. 5A) to quantify lateral ventricle 242 
volume. AAV-GFP mice were indistinguishable from naive wild-type mice at P14. In contrast, 243 
NKCC1 OE mice had reduced lateral ventricle volumes (Fig. 5A, B), without decrease in overall 244 
brain size (Fig. 5C), reflecting less circulating CSF. The difference in ventricle sizes from these 245 
same mice was sustained up to our final measurement at P50 (AAV-GFP: 3.12 ± 0.59 mm3 vs. 246 
AAV-NKCC1: 1.28 ± 0.28 mm3, * p = 0.0182). While the exact transport direction of NKCC1 in 247 
adult ChP is still under debate (Delpire and Gagnon, 2019), the consistency in ventricular 248 
volume from P14 into later life supports our working model that because a relatively small 249 
proportion of ChP NKCC1 was phosphorylated in mice P14 and older (Fig. 2G), NKCC1 levels 250 
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are not rate-limiting and thus OE would not as substantially impact ChP functions in older 251 
animals. Collectively, our findings demonstrate that ChP NKCC1 mediated CSF clearance 252 
during the first postnatal week. Augmenting this process impacted CSF volume homeostasis in 253 
the long term. 254 
We then tested and found that enhancing CSF clearance through ChP NKCC1 OE 255 
changed how the brain and cranial space adapted to CSF volume changes. Intracranial 256 
compliance (Ci) and CSF resistance (RCSF) describe the ability of the entire intracranial space 257 
(including brain, meninges, and outflow routes) to accommodate an increasing CSF volume that 258 
would otherwise increase intracranial pressure (ICP). In humans, these parameters are measured 259 
by a CSF constant rate infusion test (Aquilina et al., 2012, Eide, 2018, Lalou et al., 2018) and 260 
can aid in diagnosis and evaluation of conditions like hydrocephalus, which has decreased Ci 261 
(Kahle et al., 2016). We developed a miniaturized version of this test to determine the Ci and 262 
RCSF in mice. The constant rate infusion test artificially increases CSF volume by ICV infusion 263 
of artificial CSF (aCSF), causing ICP to rise and plateau at a new level (Fig. 5D, E). The Ci and 264 
RCSF are estimated from the ICP vs. time curve using Marmarou’s model of CSF dynamics 265 
(Czosnyka et al., 2012) (Supplementary Fig. 9A). Simply put, the Ci is proportional to the rate 266 
of ICP increase, and the RCSF is related to the level of the post-infusion ICP plateau (Fig. 5E). As 267 
a quality control for the correct placement of infusion and measurement catheter, arterial and 268 
respiratory pulsations were clearly visible in the ICP waveform and their amplitude increased 269 
with volume load as expected (Supplementary Fig. 9B, C). Using this approach, we found that 270 
ChP NKCC1 OE significantly increased Ci at an age of 5-7 weeks (Fig. 5F, G), consistent with 271 
the brain having greater capacity for CSF in ventricles “deflated” due to excessive CSF clearance. 272 
Resting ICP and RCSF were unchanged (Fig. 5H, I). 273 
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 274 
Enhanced ChP NKCC1 function mitigates ventriculomegaly in a model of obstructive 275 
hydrocephalus 276 
Our findings of enhanced CSF clearance after ChP NKCC1 OE indicate that ChP 277 
NKCC1 can remove excess CSF. Therefore, we hypothesized that ChP NKCC1 OE expression 278 
could mitigate ventriculomegaly in a model of postnatal obstructive hydrocephalus. We first 279 
overexpressed ChP NKCC1 at E14.5 by in utero AAV2/5 ICV, then introduced obstructive 280 
hydrocephalus by a single unilateral injecting of kaolin into the lateral ventricle at P4 (Shaolin et 281 
al., 2015), and finally evaluated the lateral ventricle volumes by live T2 MRI at P14 (Fig. 6A). 282 
While both NKCC1 OE and control mice had enlarged ventricles at P14, NKCC1 OE mice had 283 
reduced ventriculomegaly compared to controls, with the average ventricle volume being less 284 
than 1/3 of the controls (Fig. 6B-D; ventricles marked by blue arrows; kaolin deposits marked by 285 
red arrows). Taken together, our findings demonstrate that early, ChP targeted NKCC1 OE has a 286 
sustained and broad impact on specific volumetric and biophysical parameters of the intracranial 287 
space with potential therapeutic applications to hydrocephalus.  288 
  289 
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DISCUSSION 290 
In this study we sought to understand how CSF is cleared from the brain before the 291 
development of canonical CSF outflow routes (e.g. arachnoid granulations and meningeal 292 
lymphatics) (Antila et al., 2017, Munk et al., 2019). The intervening time period is a critical, 293 
transient phase in brain development when failure of CSF clearance has debilitating 294 
consequences (Volpe, 2008). Our results suggest that this period is defined by rapid decrease in 295 
CSF K+. The ChP mediates the CSF K+ clearance during this transition period, and thus forms a 296 
CSF outflow route through ion and water co-transport by NKCC1 (Fig. 7). This CSF clearance 297 
by the ChP contrasts the prevailing models that ChP constantly, unidirectionally secretes CSF. 298 
Taken together, we discovered an unconventional, precisely timed, function of the developing 299 
ChP that clears CSF prior to the formation of other canonical routes, and provides targets for 300 
fluid management intervention during a critical transition phase of brain development. 301 
NKCC1 is a bidirectional transporter, recently discovered to be an important co-302 
transporter of water in the adult ChP (Steffensen et al., 2018). Although clearly established as a 303 
key molecular mechanism of CSF regulation, ChP NKCC1 transport direction and its 304 
determinants in vivo have been actively debated due to the technical challenges of 1) specifically 305 
manipulating ChP NKCC1 without affecting NKCC1 in other CSF-contacting cells, instead of 306 
ICV application of chemicals such as NKCC1 inhibitor bumetanide; and 2) accurately 307 
determining intracellular ion levels of ChP epithelial cells, and therefore ion gradients, under 308 
physiological conditions, as summarized in Supplementary Table 1 and reviewed by Delpire 309 
and Gagnon (Delpire and Gagnon, 2019). Our in vivo “gain-of-function” approach effectively 310 
bypasses the abovementioned technical limitations. By overexpressing NKCC1 specifically in 311 
the ChP through AAV transduction to amplify its physiological functional impact, we could 312 
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subsequently observe the resulting CSF K+ and fluid volume changes to reveal the transporter’s 313 
native directionality. Using this approach, we found that, in contrast to the common notion that 314 
the ChP constantly produces CSF, NKCC1 in the ChP mediated CSF clearance when CSF [K+] 315 
is above adult values, especially during the first postnatal week in mice. This phase corresponds 316 
to the third trimester to 6 months after birth in human, which represents a window of high 317 
vulnerability to congenial fluid disorders (Volpe, 2008).  318 
We next demonstrated that the ChP clearance of CSF can be targeted to temper abnormal 319 
CSF accumulation. The ChP has been targeted for therapeutic manipulation in rodent models of 320 
neurologic diseases ranging from Huntington’s disease and lysosomal storage disorders, to 321 
Alzheimer’s disease, where transduction of exogenous gene products into ependymal or ChP 322 
epithelial cells has improved cardinal symptoms of disease (Kaler, 1994, Hudry et al., 2013). 323 
Encouragingly, we showed that enhancing ChP epithelial cell NKCC1 transport capacity 324 
lessened the severity of ventriculomegaly in a model of obstructive hydrocephalus. Our data 325 
demonstrate the possibility of tempering congenital hydrocephalus by augmenting endogenous 326 
ChP NKCC1 activity to increase CSF absorption rates during early development when CSF [K+] 327 
is high. In addition, because ChP CSF absorption via NKCC1 is driven by increased CSF [K+], 328 
this mechanism may come into play in other pathogenic conditions where CSF [K+] is transiently 329 
increased, such as after tissue injury or ventricular bleeding. Therefore, our findings emphasize 330 
the ChP as a targetable, K+-sensitive and on-demand CSF drainage route in neurological 331 
disorders where CSF homeostasis is disrupted. 332 
Further, in light of recent findings reporting hydrocephalus and ventriculomegaly in 333 
children with de novo loss-of-function CHD4 mutations (Weiss et al., 2020), we found that the 334 
CHD4/NuRD complex is required for the developmental regulation of NKCC1 expression. This 335 
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connection suggests a possible pathophysiological mechanism whereby lack of CHD4 activity 336 
might reduce NKCC1 levels during early development (equivalent to P0-P7 in mice), and lead to 337 
insufficient CSF clearance resulting in hydrocephalus. In our loxP-cre approach, most CHD4 338 
protein knockdown and resulting stagnation of NKCC1 expression occurred by P14, which is 339 
beyond the critical window of NKCC1 activity at P0-P7. As such, we did not model 340 
developmental ventriculomegaly with this approach. Improved genetic tools for early CHD4 341 
knockout and new animal models harboring the de novo patient mutations would be required to 342 
fully unravel the regulatory connection between CHD4/NuRD complex and NKCC1. 343 
A key question that emerges from this work is: If the ChP is acting as an outflow 344 
pathway rather than a source of CSF during this transitional developmental phase – where does 345 
the early CSF water content come from? One mechanism that could be acting at this stage is CSF 346 
secretion by the developing brain tissue (e.g. progenitor cells that have a cell body at the 347 
ventricular zone but extend their basal processes to the developing pia) which secretes CSF 348 
immediately after neural tube closure (Gato et al., 2014). Future studies should elucidate whether 349 
this mechanism extends into this transitional phase. Consistent with progenitor involvement in 350 
CSF dynamics, recent identification of genes driving pediatric hydrocephalus shows affected 351 
genes to be expressed predominantly by cortical progenitor cells lining the brain’s ventricles 352 
(Furey et al., 2018), and not the ChP, suggesting a non-choroidal source of CSF as an alternative 353 
contributor to abnormal CSF production. 354 
 In addition to fluid regulation, the newly identified ChP clearance route provides a key 355 
mechanism to regulate extracellular K+ during the first postnatal week. The subunits of the major 356 
system for moving K+ against its individual concentration gradient, the Na+/K+-ATPase (i.e. 357 
Atp1a1 and Atp1b1), were not yet at their full expression levels during this period. The ChP 358 
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NKCC1-mediated K+ clearance mechanism might assist in establishing the K+ gradient in a 359 
timely manner, which is crucial for cellular physiology (Rasmussen et al., 2020). Notably, the 360 
period of rapidly decreasing CSF [K+] overlaps with the developmental phase when the 361 
excitatory-to-inhibitory “GABA switch” occurs. In early cortical progenitor cells that reside in 362 
the ventricular zone and are bathed by CSF, the classic inhibitory neurotransmitter GABA leads 363 
to excitatory potentials and suppression of DNA synthesis (LoTurco et al., 1995). As newborn 364 
cortical neurons differentiate and migrate away from the ventricular zone, GABA switches to 365 
adopt the more classic role as an inhibitory neurotransmitter by lowering intracellular Cl- (Owens 366 
et al., 1999) which is achieved through coordinated activities of neuronal K+/Cl- co-transporters 367 
KCC2 and NKCC1 (Pisella et al., 2019, Watanabe et al., 2019). Because ions, including K+, can 368 
traffic from CSF into interstitial fluid (Cserr, 1965, Fencl et al., 1966), any interference with the 369 
developmental timeline of ChP NKCC1 that resulted in delayed CSF K+ clearance could 370 
potentially increase extracellular/interstitial fluid [K+] and affect neural physiology (Rasmussen 371 
et al., 2020). Specifically, such a change in extracellular/interstitial fluid [K+] could 372 
fundamentally impact neuronal NKCC1 and KCC2 transport equilibrium, potentially 373 
contributing to a delayed GABA switch, a phenomenon reported in many models of 374 
neurodevelopmental and psychiatric disorders including subtypes of autism spectrum disorder 375 
(Amin et al., 2017), Rett syndrome (Banerjee et al., 2016), Fragile X syndrome (He et al., 2014), 376 
schizophrenia (Hyde et al., 2011), and Down syndrome (Deidda et al., 2015). Furthermore, 377 
extracellular [K+] and certain K+ channels also regulate activities of microglia (Madry et al., 378 
2018), which are critical in synaptic pruning during postnatal neurodevelopment in mice 379 
(Schafer et al., 2012). Thus, the ChP is poised to play important roles in proper CNS formation 380 
by creating and maintaining desirable extracellular ionic homeostasis at different developmental 381 
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stages, with subsequent effects on neuronal maturation, circuit formation, and 382 
neuroinflammatory homeostasis. 383 
Beyond key findings and implications during this critical transitional developmental stage, 384 
our study introduced a murine ICP measurement device combined with constant CSF infusion. 385 
This approach provides a much-needed advance in fluid research technology that can be broadly 386 
applied to study essentially all CSF dynamic systems across the mouse lifespan. We adapted our 387 
tool from clinical practice to provide a range of options for measuring global cerebral fluid states 388 
that reflect the interaction between CSF and cranial tissues. In later life, CSF homeostasis is 389 
maintained by collaborative efforts from multiple players in the brain, including the ChP, the 390 
dural lymphatics (Antila et al., 2017), glymphatics (Munk et al., 2019), leptomeningeal 391 
vasculature (Li et al., 2020), and the ependyma (Spassky et al., 2005). While this approach 392 
measures overall cranial fluid dynamics as one single unit, future applications could apply 393 
mathematical models that have been proposed to isolate the contribution of distinct CSF outflow 394 
routes using data acquired from human patients (Vinje et al., 2020). Such adaptability secures the 395 
broadening relevance of our tool and inspires optimism for further improved resolution in 396 
studying brain fluid dynamics. Availability of this new tool also allows future researchers to 397 
obtain measurements in support of the growing comprehensive “systems” view of regulatory 398 
mechanisms of CSF-brain interactions.  399 
In summary, our study presents a critical transient phase when the ChP acts as a non-400 
canonical route for CSF clearance prior to the maturation of other canonical clearance pathways. 401 
ChP NKCC1 mediates CSF clearance in a K+-dependent manner. Targeting this absorption route 402 
holds promise in improving fluid management for congenital hydrocephalus and other CSF 403 
disorders.   404 
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METHODS 428 
Mice 429 
The Boston Children’s Hospital IACUC approved all experiments involving mice in this 430 
study. Timed pregnant CD1 dams were obtained from Charles River Laboratories. Mice with 431 
germline loxP-CHD4-loxP were imported from MGH and bred in-house. Both male and female 432 
mice were equally included in the study and were analyzed at postnatal day 0, 7, 14, 21, 28, 5-433 
7weeks, and 2+ months. Animals were housed in a temperature-controlled room on a 12-hr 434 
light/12-hr dark cycle and had free access to food and water. For studies involving mice younger 435 
than postnatal day 10, all mice were allocated into groups based solely on the gestational age 436 
without respect to sex (both males and females were included). For studies involving mice older 437 
than 10 days, both male and female are included intentionally. 438 
CSF Collection and Metal Detection 439 
CSF was collected by from cisterna magna using a glass capillary, and collected CSF was 440 
centrifuged at 10,000xg for 10min at 4℃ to remove any tissue debris. Metal quantifications were 441 
performed by Galbraith Laboratories, Inc. (Knoxville, TN, USA). Inductively coupled plasma - 442 
optical emission spectrometry (ICP-OES) was used for K and Na quantification, and ion 443 
chromatography (IC) was used for the Cl- quantification. All tests were performed using 5-7µL 444 
of CSF. 445 
TRAP 446 
Mice aged 8 weeks or E16.5 from the Foxj1:Cre x EGFP-L10a Bacterial Artificial 447 
Chromosome (BAC) transgenic lines (N=3, each N included LVChP pooled from 3 mice) were 448 
used and brain tissue was immediately dissected and used for TRAP RNA purifications as 449 
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previously described (Heiman et al., 2008). RNA quality was assessed using Bioanalyzer Pico 450 
Chips (Agilent, 5067-1513) and quantified using Quant-iT RiboGreen RNA assay kit (Thermo 451 
Fisher Scientific R11490). Libraries were prepared using Clonetech SMARTer Pico with 452 
ribodepletion and Illumina HiSeq to 50NT single end reads. Sequencing was performed at the 453 
MIT BioMicroCenter. 454 
Sequencing Data Analysis 455 
The raw fastq data of 50-bp single-end sequencing reads were aligned to the mouse 456 
mm10 reference genome using STAR 2.4.0 RNA-Seq aligner (Dobin et al., 2013). The mapped 457 
reads were processed by htseq-count of HTSeq software (Anders et al., 2015) with mm10 gene 458 
annotation to count the number of reads mapped to each gene. The Cuffquant module of the 459 
Cufflinks software (Trapnell et al., 2010) was used to calculate gene FPKM (Fragments Per 460 
Kilobase of transcript per Million mapped reads) values. Gene differential expression test 461 
between different animal groups was performed using DESeq2 package (Love et al., 2014) 462 
with the assumption of negative binomial distribution for RNA-Seq data. Genes with adjusted p-463 
value< 0.05 are chosen as differentially expressed genes. All analyses were performed using 464 
genes with FPKM> 1, which we considered as the threshold of expression (Figure 2- source 465 
data).  466 
Sequencing Pathway and Motif Analysis 467 
Functional annotation clustering was performed using DAVID v6.7 (Huang da et al., 468 
2009). Gene ontology (GO) analysis was performed using AdvaitaBio iPathway guide V.v1702. 469 
Enrichment vs. perturbation analysis was performed by AdvaitaBio iPathway guide V.v1702 and 470 
allows comparison of pathway output perturbation and cumulative gene set expression changes. 471 
In brief, the enrichment analysis is a straightforward gene-set enrichment over representation 472 
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analysis (ORA) considering the number of differentially expressed genes (DEGs) that are 473 
assigned to a given pathway. The enrichment value is expressed as a proportion of enriched 474 
members to total genes in a defined pathway and a p-value (Fisher) is calculated for this score, 475 
however false positives have been reported at up to 10% with this method (Draghici et al., 2007). 476 
Perturbation, on the other hand, uses pathway data that applies relationships between gene 477 
products rather than only using a list. Perturbation assigns an impact score based on a 478 
mathematical model that captures the entire topology of the pathway and uses it to calculate how 479 
changes in the expression of each gene in the pathway would perturb the absolute output of the 480 
pathway (Draghici et al., 2007). Then, these gene perturbations are combined into a total 481 
perturbation for the entire pathway and a p-value is calculated by comparing the observed value 482 
with what is expected by chance. Motif analyses were performed using SignalP (v5.0; Almagro 483 
Armenteros et al., 2019) and TMHMM (v2.0; Sonnhammer et al., 1998). 484 
Transmission Electron Microscopy  485 
All tissue processing, sectioning, and imaging was carried out at the Conventional 486 
Electron Microscopy Facility at Harvard Medical School. Forebrain tissues were fixed in 2.5% 487 
Glutaraldehyde/2% Paraformaldehyde in 0.1 M sodium cacodylate buffer (pH 7.4). They were 488 
then washed in 0.1M cacodylate buffer and postfixed with 1% Osmiumtetroxide (OsO4)/1.5% 489 
Potassiumferrocyanide (KFeCN6) for one hour, washed in water three times and incubated in 1% 490 
aqueous uranyl acetate for one hour. This was followed by two washes in water and subsequent 491 
dehydration in grades of alcohol (10 minutes each; 50%, 70%, 90%, 2x10min 100%). Samples 492 
were then incubated in propyleneoxide for one hour and infiltrated overnight in a 1:1 mixture of 493 
propyleneoxide and TAAB Epon (Marivac Canada Inc. St. Laurent, Canada). The following day, 494 
the samples were embedded in TAAB Epon and polymerized at 60 degrees C for 48 hours. 495 
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Ultrathin sections (about 80nm) were cut on a Reichert Ultracut-S microtome, and picked up 496 
onto copper grids stained with lead citrate. Sections were examined in a JEOL 1200EX 497 
Transmission electron microscope or a TecnaiG² Spirit BioTWIN. Images were recorded with an 498 
AMT 2k CCD camera.  499 
Glycogen and Mitochondrial Quantification  500 
Glycogen and mitochondrial quantification was performed by hand using the ImageJ 501 
plugin FIJI (Schindelin et al., 2012, Schneider et al., 2012). Percentages were calculated by 502 
dividing the area of interest by the total area of ChP epithelial cell within the field of view. No 503 
other cell types were included in the analysis. For each condition, analyses were performed 504 
across multiple individual animals (N=3 for each age). From each animal, 10-20 fields of view 505 
were imaged at 3,000x for glycogen analysis and 5-10 fields of view were imaged at 3,000x for 506 
mitochondrial analysis. Each different field of view represented a unique cell or cells, and fields 507 
of view were chosen such that both the apical and basal surfaces of the cell were visible. For 508 
mitochondrial distribution, a custom MatLab (v.2018) code was written to extract the centroid 509 
from mitochondria data traced in ImageJ ROIs (Supplementary file). Then a distance 510 
transformation was performed from each mitochondrion centroid to the hand-traced apical or 511 
basal surfaces. The shortest distance was extracted to calculate the apical: basal proximity ratio, 512 
such that 1= on the apical surface and 0= on the basal surface. The analyses included a total of 513 
1747 adult mitochondria, 2241 P7 mitochondria, 2257 P0 mitochondria, and 1123 embryonic 514 
mitochondria. 515 
Seahorse Metabolic Analysis 516 
ChP explants were dissected in HBSS (Fisher, SH30031FS) and maintained on wet ice 517 
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until plated. Only the posterior leaflet of the P0, P7, and adult ChP was retained for analysis due 518 
to empirically determined limitations of the oxygen availability in the XFe96 Agilent Seahorse 519 
system. Tissue explants were plated on Seahorse XFe96 spheroid microplates (Agilent, 102905-520 
100) coated with Cell TAK (Corning), in Seahorse XF Base Medium (Agilent, 102353-100) 521 
supplemented with 0.18% glucose, 1mM L-glutamine, and 1mM pyruvate at pH7.4 and 522 
incubated for 1 hour at 37 °C in a non-CO2 incubator. Extracellular acidification rates (ECAR) 523 
and oxygen consumption rates (OCR) were measured via the Cell Mito Stress Test (Agilent, 524 
103015-100) with a Seahorse XFe96Analyzer (Agilent) following the manufacturer’s protocols. 525 
Data were processed using Wave software (Agilent). ATP production was calculated as the 526 
difference in OCR measurements before and after oligomycin injection, as described by the 527 
manufacturer's protocol (Agilent, 103015-100). The Cell Mito Stress test was performed 2-5 528 
independent times. The individual analyses were performed by averaging the readings from both 529 
the right and left hemisphere lateral ventricle ChP for each individual. Data were normalized by 530 
Calcein-AM (2µM in PBS, Life Technologies L-3224) fluorescence measured at the end of the 531 
assay. Data are presented normalized to the adult levels for each assay to account for any 532 
experimental variability.  533 
High K+ challenge study 534 
 Fresh LV ChPs were collected from P4 pups and adult mice in room temperature HBSS 535 
and glued down onto imaging dishes with coverslip bottom. The tissues were incubated at 37 °C 536 
with Calcein-AM (Invitrogen L3224; 1:200) for 10min and then rinsed with 37 °C  artificial CSF 537 
(aCSF: 119 mM NaCl, 2.5 mM KCl, 26 mM NaHCO3, 1 mM NaH2PO4, 11 mM glucose, with 538 
fresh 2.0 mM magnesium chloride and 2.8 mM calcium chloride). The tissues were soaked in 539 
1.8ml aCSF at the beginning of each imaging session and allowed to stabilize for 10min. One Z-540 
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stack was acquired to reflect the baseline cell volume. Then a 10x KCl solution in aCSF was 541 
spiked into the bath to make the final bath K+ concentration 50mM immediately before imaging 542 
subsequent continued. A total of five 3D Z-stacks were acquired throughout a 10-min imaging 543 
session to capture changes in cellular volume over time. Each stack took less than 30s to 544 
minimize changes in cell volume from the beginning to the end of each stack. All imaging 545 
studies were carried out at 37°C. Image stacks were imported into Imaris (Bitplane) software. 546 
Individual epithelial cells were identified by shape. Cells with discrete borders that were present 547 
at all timepoints and had dark pixels both above and below them in Z for the whole timecourse 548 
were selected a priori and then traced by hand using the “Surpass” functionality to create a 3D 549 
surface volume through all Z stacks based on Calcein-AM uptake signal. Due to known z-step 550 
distance and interpolation between the planes, Imaris calculated the number of voxels for each 551 
cell. This analysis was then repeated for the same cell throughout the timecourse. We verified 552 
manually that the cell was the same individual based on the topology of the surrounding cells, 553 
allowing for adjustment for any x-y drifting that occurred. The relative volume was calculated as 554 
dV/V0 for each timepoint (t) where V0 is the initial volume of the cell, t is each subsequent 555 
timepoint after addition of challenge, and dV= Vt-V0. 556 
Tissue processing 557 
Samples were fixed in 4% paraformaldehyde (PFA). For cryosectioning, samples were 558 
incubated in the following series of solutions: 10% sucrose, 20% sucrose, 30% sucrose, 1:1 559 
mixture of 30% sucrose and OCT (overnight), and OCT (1 hour). Samples were frozen in OCT.  560 
Immunostaining 561 
Cryosections were blocked and permeabilized (0.3% Triton-X-100 in PBS; 5% serum), 562 
incubated in primary antibodies overnight and secondary antibodies for 2 hours. Sections were 563 
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counterstained with Hoechst 33342 (Invitrogen H3570, 1:10000) and mounted using 564 
Fluoromount-G (SouthernBiotech). The following primary antibodies were used: chicken anti-565 
GFP (Abcam ab13970; 1:1000), mouse anti-Aqp1 (Santa Cruz sc-32737; 1:100), rabbit anti-566 
CHD4 (Abcam ab72418, 1:200), rabbit anti-NKCC1 (Abcam ab59791; 1:500), rat anti-HA 567 
(Roche 11867423001; 1:1000). Secondary antibodies were selected from the Alexa series 568 
(Invitrogen, 1:500). Images were acquired using Zeiss LSM880 confocal microscope with 20x 569 
objective. 570 
Co-IP 571 
Tissues were homogenized in NET buffer (150mM NaCl, 10mM Tris 8.0, 5mM EDTA, 572 
10% glycerol and 2% Triton-100) supplemented with protease inhibitors. Protein concentration 573 
was determined by BCA assay (Thermo Scientific 23227). Lysates with same amount of total 574 
protein (250-1000µg based on experiments) were pre-cleared at 4° C for 2hr with Protein G 575 
agarose and then incubated with desired antibody or control antibody at 4° C overnight (no beads 576 
present during antibody incubation). Protein G agarose beads were added to lysate-antibody 577 
mixture after overnight incubation for 2hr. Beads were washed thoroughly and then eluted by 578 
boiling in 2% SDS. ChP tissues were pooled across 7 litters of P0 pups and 30 adults to achieve 579 
sufficient protein for Co-IP. 580 
Immunoblotting  581 
Tissues were homogenized in RIPA buffer supplemented with protease and phosphatase 582 
inhibitors. Protein concentration was determined by BCA assay (Thermo Scientific 23227). 583 
Samples were denatured in 2% SDS with 2-mercaptoethanol by heating at 37°C (for NKCC1) or 584 
95°C (for CHD4 and other NuRD complex proteins) for 5 minutes. Equal amounts of proteins 585 
were loaded and separated by electrophoresis in a 4-15% gradient polyacrylamide gel (BioRad 586 
.CC-BY-NC-ND 4.0 International license(which was not certified by peer review) is the author/funder. It is made available under a
The copyright holder for this preprintthis version posted August 4, 2020. . https://doi.org/10.1101/2020.08.03.234260doi: bioRxiv preprint 
Xu and Fame, et al. 27 
#1653320) or NuPAGE 4-12% Bis-Tris gel (Invitrogen #NP0322), transferred to a nitrocellulose 587 
membrane (250mA, 1.5 hours, on ice), blocked in filtered 5% BSA or milk in TBST, incubated 588 
with primary antibodies overnight at 4°C followed by HRP conjugated secondary antibodies 589 
(1:5000) for 1 hour, and visualized with ECL substrate. For phosphorylated protein analysis, the 590 
phospho-proteins were probed first, and then blots were stripped (Thermo Scientific 21059) and 591 
reprobed for total proteins. For co-IP protein analysis, TrueBlot secondary antibody (eBioscience 592 
18-8816-33) was used to detect only non-denatured IgG and avoid background signal from IP 593 
antibody. The following primary antibodies were used: rabbit anti-NKCC1 (Abcam ab59791; 594 
1:1000), rabbit anti-pNKCC1 (EMD Millipore ABS1004; 1:1000), rabbit anti-ATP1a1 (Upstate 595 
C464.6/05-369; 1:250, goat-anti-klotho (R&D AF1819-sp; 1:200), rabbit anti-GAPDH (Sigma 596 
G9545; 1:10000), mouse anti-HA (Abcam ab130275; 1:1000), rabbit anti-CHD4 (Abcam 597 
ab72418; 1:2000), rabbit anti-MBD3 (Abcam ab157464; 1:1000), rabbit anti-HDAC1 (Abcam 598 
ab7028; 1:2000), mouse anti-HDAC2 (Abcam 51832; 1:2000). 599 
Quantitative RT-PCR 600 
For mRNA expression analyses, the ChP were collected and pooled from 2 pups. RNA 601 
was isolated using the MirVana miRNA isolation kit (Invitrogen AM1561) following 602 
manufacturer’s specifications without miRNA enrichment step. Extracted RNA was quantified 603 
spectrophotometrically and 100ng was reverse-transcribed into cDNA using the High Capacity 604 
cDNA Reverse Transcription kit (Applied Biosystems #4368814) following manufacturer’s 605 
specifications. RT-qPCRs were performed in duplicate using Taqman Gene Expression Assays 606 
and Taqman Gene Expression Master Mix (Applied Biosystems) with GAPDH as an internal 607 
control. Cycling was executed using the StepOnePlus Real-Time PCR System (Invitrogen) and 608 
analysis of relative gene expression was performed using the 2-ΔΔCT method. Technical replicates 609 
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were averaged for their cycling thresholds and further calculations were performed with those 610 
means. 611 
In utero intracerebroventricular injection (ICV) 612 
Timed pregnant mice (E14.5) were deeply anesthetized by isoflurane and placed on warm 613 
pads. Laparotomy was performed and AAV solution was delivered into the lateral ventricle of 614 
each embryo using glass capillary pipettes. The abdominal incision was then sutured. Meloxicam 615 
analgesia was longitudinally delivered according to IACUC protocol. 616 
Intraventricular kaolin injection in postnatal pups 617 
 Postnatal day 4 pups (P4) were deeply anesthetized by hypothermia. 1µl of sterile kaolin 618 
solution (25% in PBS) was delivered into the left lateral ventricle using glass capillary pipettes. 619 
The lateral ventricle location was determined as in between bregma and lambda, and 1mm from 620 
mid-line. The pups were then warmed and returned to the dam. 621 
AAV production 622 
The original AAV-NKCC1 plasmid was purchased from Addgene (pcDNA3.1 HA CFP 623 
hNKCC1 WT (NT15-H) was a gift from Biff Forbush: Addgene plasmid # 49077; 624 
http://n2t.net/addgene:49077; RRID:Addgene_49077). The plasmid carries an 3xHA tag at the 625 
N-terminal of NKCC1 to allow detection and separation from endogenous NKCC1. The CFP tag 626 
was removed by BsaI digestion to reduce insert size for AAV production. Virus production and 627 
purification were performed by the Penn Vector Core. Due to the very large size of the plasmid 628 
we experienced variable infection efficiency. All mice receiving AAV-NKCC1 were analyzed 629 
for HA expression after every experiment to confirm infection efficiency. AAV-GFP and AAV-630 
Cre were purchased from BCH viral core at Boston Children’s Hospital. 631 
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Magnetic resonance imaging (MRI) 632 
Mice were imaged using Bruker BioSpec small animal MRI (7T) at 2wk and P50 while 633 
under anesthesia by isoflurane. A warm pad was used to maintain body temperature. Breathing 634 
rate and heart rate were monitored to reflect the depth of anesthesia. All axial T2 images were 635 
acquired using the following criteria: TE/TR=60/4000; Ave=8; RARE=4; slice thickness=0.6mm. 636 
Ventricle volumes were calculated by manual segmentation using FIJI/ImageJ. In studies with 637 
unilateral kaolin injection, 3D reconstruction of the ventricles was performed by manual 638 
segmentation in ITK-SNAP (Madan, 2015) and exported through ParaView. 639 
Constant rate CSF infusion test (ICP and compliance measurement) 640 
An apparatus was developed to perform a constant infusion test in mice through a single 641 
catheter for both infusion of CSF and monitoring of ICP. A 20cc syringe was filled with aCSF 642 
and placed in an automated infusion pump (GenieTouch, Kent Scientific Co., Denver) and set to 643 
deliver a constant rate infusion of 1-4 uL/minute. The syringe was connected via pressure tubing 644 
to hemostasis valve Y connector (Qosina, NY). A fiberoptic ICP sensor (Fiso Technologies Inc, 645 
Québec, Canada) was inserted through the other port of the rotating hemostat and then into 0.55 646 
mm diameter catheter until the sensor was flush with the catheter’s distal tip. The entire 647 
apparatus and tubing was carefully screened to ensure the absence of air bubbles. Adult mice 648 
were then deeply anesthetized, placed on a warm pad, and head-fixed with ear bars. The distal 649 
end of the infusion device (catheter with fiberoptic sensor) was placed inside lateral ventricle (-650 
0.4mm (anterior-posterior) and 1.2mm (medial-lateral) with respect to Bregma, and a depth of 2 651 
mm from the outer edge of the skull); the catheter was then sealed with Vetbond (3M, 652 
Minnesota). Intraventricular access and water-tight seal was confirmed by observation of arterial 653 
and respiratory waveforms in the ICP signal and a transient rise in ICP upon gentle compression 654 
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of the abdomen and thorax. Two minutes of baseline ICP were recorded before initiating the 655 
infusion of aCSF. As the infusion proceeded, careful observation was made of the mouse’s 656 
respiratory rate. After the ICP level reached a new plateau, the infusion was discontinued. The 657 
procedure was terminal. Parameters of the Marmarou model of CSF dynamics for constant rate 658 
infusions were estimated by a non-linear least squares fit of the model to the ICP data (Czosnyka 659 
et al., 2012) 660 
𝐼𝐶𝑃 𝑡 =  
𝑖!"#$%!&" +
𝐼𝐶𝑃!"#$%&'$ − 𝑝!
𝑅!"#
∙ 𝐼𝐶𝑃!"#$%&'$ − 𝑝!
𝐼𝐶𝑃!"#$%&'$ − 𝑝!
𝑅!"#
+ 𝑖!"#$%!&" ∙ 𝑒
!
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!!"#
∙
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where iinfusion is the rate of infusion, ICPbaseline is the ICP level before infusion, p0 is a pressure in 661 
the storage arm of the model, RCSF is the resistance to CSF outflow, and Ci is the compliance 662 
coefficient. 663 
QUANTIFICATION AND STATISTICAL ANALYSIS 664 
Biological replicates (N) were defined as samples from distinct individual animals, 665 
analyzed either in the same experiment or within multiple experiments, with the exception when 666 
individual animal could not provide sufficient sample (i.e. CSF), in which case multiple animals 667 
were pooled into one biological replicate and the details are stated in the corresponding figure 668 
legends. Statistical analyses were performed using Prism 7 or R. Outliers were excluded using 669 
ROUT method (Q = 1%). Appropriate statistical tests were selected based on the distribution of 670 
data, homogeneity of variances, and sample size. The majority of the analyses were done using 671 
One-way ANOVA with multiple comparison correction (Sidak) or Welch’s unpaired t-test, 672 
except for Fig. 1E-G, and Fig. 1I-J where the analysis was done by Welch’s ANOVA with 673 
Dunnett’s T3 multiple comparison test, and Fig. 1L where the analysis was done using 674 
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Kolmogorov-Smirnov test. F tests or Bartlett’s tests were used to assess homogeneity of 675 
variances between data sets. Parametric tests (t-test, ANOVA) were used only if data were 676 
normally distributed and variances were approximately equal. Otherwise, nonparametric 677 
alternatives were chosen. Data are presented as means ± standard deviation (SD). If multiple 678 
measurements were taken from a single individual, data are presented as means ± standard errors 679 
of the mean (SEMs). Please refer to figure legends for sample size. p values < 0.05 were 680 
considered significant (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001). Exact p values 681 
can be found in the figure legends. P values are also marked in the figures where space allows. 682 
  683 
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Fig. 1. Postnatal CSF [K+] decrease coincides with increased ChP metabolism. (A) ICP-OES 907 
quantification of CSF [K+]. N = 6, **** p < 0.0001 by one-way ANOVA. Sidak’s test was used 908 
for P0 vs. P7 and P0 vs. adult comparison. *** p = 0.0009, **** p < 0.0001. (B) ICP-OES and 909 
IC measurements of E14.5 and adult mouse CSF [Na+] and [Cl-]. N=3; Welch’s t-test. (C) ICP-910 
OES measurements of embryo vs. adult mouse serum [K+]. N=3. (D) Transmission micrographs 911 
of mitochondria in LVChP. (E-G) Quantification of mitochondrial number (E), area (F), and % 912 
area occupancy (G) in ChP epithelial cells. N =3 animals, 5-10 FOV per animal, *p < 0.05, **p 913 
< 0.01, ***p < 0.005, ****p < 0.001; Welch’s t-test. (H) Schematic of explant-based Agilent 914 
Seahorse XFe96 test. (I-J) Oxidative respiration metrics over development. *p < 0.05, **p < 915 
0.01, ****p < 0.0001; Welch’s ANOVA with Dunnett’s T3 multiple comparison test. (K-L) 916 
Mitochondrial distribution between the apical and basal surfaces (Apical: Basal proximity ratio). 917 
1 = apical surface. 0 = basal surface. Solid line indicates median and dashed line indicates 918 
upper/lower quartiles. **** p < 0.0001; Kolmogorov–Smirnov test. (M) Cumulative distribution 919 
of mitochondrial localization. Solid lines are the mean, shaded area represents the range. Scale 920 
bar (d) = 250nm, (k) = 2µm. Unless otherwise noted, all quantitative data are presented as Mean 921 
± SEM.  922 
  923 
.CC-BY-NC-ND 4.0 International license(which was not certified by peer review) is the author/funder. It is made available under a
The copyright holder for this preprintthis version posted August 4, 2020. . https://doi.org/10.1101/2020.08.03.234260doi: bioRxiv preprint 
Xu and Fame, et al. 40 
 924 
.CC-BY-NC-ND 4.0 International license(which was not certified by peer review) is the author/funder. It is made available under a
The copyright holder for this preprintthis version posted August 4, 2020. . https://doi.org/10.1101/2020.08.03.234260doi: bioRxiv preprint 
Xu and Fame, et al. 41 
Fig. 2. Choroid plexus epithelial cells display age-dependent translation of ion and water 925 
transporters, in particular NKCC1. (A) Rpl10a-conjugated EGFP expression in ChP epithelial 926 
cells after Foxj1-Cre recombination in TRAP-BAC mice. (B) Heatmap and hierarchical 927 
clustering of differentially expressed genes (adjusted p < 0.05). (C) Top 4 gene functional 928 
clusters shown by DAVID to be enriched in Adult ChP epithelial cells over E16.5 ChP epithelial 929 
cells. (D) Top 10 significantly enriched gene ontology (GO) terms for “Biological processes”. 930 
Plotted with boxes for quartiles and whiskers for 5th and 95th percentiles. The log10 fold change 931 
(LogFC) is plotted for each expressed gene for the network. Positive values (red) indicate Adult 932 
enrichment and negative values (blue) indicate E16.5 enrichment. p values are corrected for 933 
multiple measures using Bonferroni correction. **p ≤0.01, ***p ≤0.001, ****p ≤0.0001. (E) 934 
Schematics demonstrating the interaction of NKCC1, Na+/K+-ATPase, and Klotho on the apical 935 
membrane of a ChP epithelial cell (CPEC). (F-G) RT-qPCR and immunoblotting of LVChP 936 
during postnatal development. (H) Fluorescence images of Calcein-AM labeled epithelial cells 937 
from LVChP explants under high extracellular K+ challenge. Scale bar = 50µm. (I-J) 938 
Quantification of ChP epithelia cellular volume by IMARIS 3D analysis. Percent volume 939 
increase = dV/V0 for each timepoint (t). V0 = initial volume of the cell; t = subsequent timepoint 940 
after addition of challenge; dV= Vt -V0 x 100%. At least 10 cells were analyzed for each explant 941 
from one animal; N = 4. 942 
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Fig. 3. NKCC1 temporal expression requires CHD4/NuRD complex. (A) RNAseq data 944 
showing expression of CHD and other NuRD units by the ChP. (B) Immunofluorescence images 945 
of CHD4 in the ChP epithelia at E16.5, P0, and adult; Scale bar = 30µm. (C) Immunoblots of 946 
Co-IP by CHD4 antibody. (D) RT-qPCR of CHD4 transcripts in ChP with AAV2/5-Cre 947 
infection.**** p< 0.0001, N = 7, Welch’s t-test. (E) Immunoblot of CHD4 in AAV-cre mice 948 
ChP lysate with. (F) RT-qPCR of NKCC1 expression in AAV-cre vs. AAV-GFP mice ChP. All 949 
values were normalized to P7 AAV-GFP control mice. **p = 0.0015, ***p < 0.001, N = 7, 950 
Welch’s t-test. (G) Immunoblot of NKCC1 in LVChP lysates from AAV-cre vs. AAV-GFP mice. 951 
(H-I) CHD4 and NKCC1 RT-qPCR in 4VChP. ** p = 0.0083, *** p < 0.001, **** p < 0.0001, 952 
N = 7, Welch’s t-test. 953 
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Fig. 4. ChP NKCC1 actively mediates CSF K+ clearance in the first postnatal week. (A) RT-956 
qPCR of NKCC1 mRNA levels in P0 mice. ** p = 0.009, N=3; Welch’s t-test. (B) Immunoblots 957 
from AAV-NKCC1 vs. AAV-GFP P0 mice ChP lysates. (C-D) Quantification of all 958 
immunoblots of NKCC1 (C) *** p = 0.0009, N=7; Welch’s t-test; and pNKCC1 (D) * p = 959 
0.0355, N=5; Welch’s t-test. (E) Immunofluorescence images showing co-localization of 3xHA 960 
tag and NKCC1 in P0 ChP. Scale bar = 50µm. (F-I) Immunofluorescence images of HA in 961 
AAV2/5-NKCC1 transduced brain at P1: the LVChP (F), 3rd ventricle ChP (3VChP; G), 4VChP 962 
(H), and the spinal cord (I; sc = spinal cord). Traces of HA is shown in the meninges near the 963 
injection site (grey arrow). Scale bar = 500µm. (J) ICP-OES measurements of CSF [K+] from 964 
AAV-NKCC1 vs. AAV-GFP P1 mice (N = 8 in AAV-GFP cohort; N = 7 in AAV-NKCC1 965 
cohort). **p = 0.0033; Welch’ t-test. 966 
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Fig. 5. ChP NKCC1 overexpression reduces brain ventricular volume and increases 971 
intracranial compliance. (A) T2-weighted live MRI images. Only slices with visible LV are 972 
shown (marked red in the schematics). (B) LV volumes. Uninjected N = 4; AAV-GFP and AAV-973 
NKCC1 N = 6; ****p < 0.0001; Welch’s t-test. (C) Brain sizes, which are presented as the 974 
average coronal section area from all images with visible ventricles (NKCC1 OE data were 975 
calculated using the matching images to the controls, regardless of ventricles visibility). 976 
Uninjected N = 4; AAV-GFP and AAV-NKCC1 N = 6; Welch’s t-test.  (D) Schematic of in vivo 977 
constant rate CSF infusion test. (E) Example of ICP curve during the infusion test (infusion 978 
begins at 0 min) in an AAV-GFP mouse, fitted to Marmarou’s model. Values extracted include: 979 
baseline ICP (ICPb), a pressure-independent compliance coefficient (Ci) and the resistance to 980 
CSF outflow (RCSF). (F) Example ICP recordings from AAV-NKCC1 mice and controls. For 981 
clarity, data have been low pass filtered to remove the waveform components. (G) Compliance 982 
coefficients. Uninjected N = 4; AAV-GFP N = 8; AAV-NKCC1 N = 9; *p = 0.0384; Welch’s t-983 
test. (H-I) Plots of baseline ICP and resistance to CSF outflow (RCSF) at 5-7 weeks. Uninjected 984 
N=4, AAV-GFP N=8, AAV-NKCC1 N=9; Welch’s t-test. 985 
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Fig. 6. ChP NKCC1 overexpression mitigates ventriculomegaly in an obstructive 988 
hydrocephalus model. (A) Schematics showing the workflow: E14.5 in utero ICV of AAV2/5-989 
NKCC1 or AAV2/5-GFP, followed by ICV of kaolin at P4, and MRI at P14. (B) Representative 990 
sequential brain images (rostral to caudal) by T2-weighted live MRI images. Blue arrows: LV. 991 
Red arrows: kaolin. (C) 3D reconstruction of the LV and kaolin deposition. LV: blue. Kaolin: 992 
red. (D) LV volumes. N = 3;  *p = 0.0.0235; Welch’s t-test. 993 
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Fig. 7. Working model of ChP NKCC1 mediating K+-driven CSF outflow. The schematics 995 
describes ChP NKCC1 mediated K+ and water clearance from CSF in neonatal mice, in 996 
comparison to the adult scenario. For simplicity and clarity, only K+ is depicted among all ions 997 
and only NKCC1 and Na+/K+-ATPase are included. Neonatal (P0-7, left) ChP has high pNKCC1 998 
than adult, albeit lower total NKCC1. Neonate CSF [K+] is 2-3 fold higher than adult. With 999 
similar [Na+] and [Cl-], this [K+] difference is sufficient to alter the total Nernst potential of 1000 
epithelial cells and bias NKCC1 transport of K+, together with water, out of CSF into the ChP in 1001 
neonates. 1002 
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